PL328228A1 - 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system - Google Patents

1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system

Info

Publication number
PL328228A1
PL328228A1 PL97328228A PL32822897A PL328228A1 PL 328228 A1 PL328228 A1 PL 328228A1 PL 97328228 A PL97328228 A PL 97328228A PL 32822897 A PL32822897 A PL 32822897A PL 328228 A1 PL328228 A1 PL 328228A1
Authority
PL
Poland
Prior art keywords
piperidines
indol
pyrazol
ethyl
nervous system
Prior art date
Application number
PL97328228A
Other languages
English (en)
Inventor
Henning Boettcher
Joachim Maerz
Gerd Bartoszyk
Hartmut Greiner
Juergen Harting
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL328228A1 publication Critical patent/PL328228A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL97328228A 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system PL328228A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602505A DE19602505A1 (de) 1996-01-25 1996-01-25 1-(Pyrazol-4-Indol-3-yl)-Piperidine
PCT/EP1997/000187 WO1997027186A1 (de) 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine als das zentralnervensystem beeinflussende mittel

Publications (1)

Publication Number Publication Date
PL328228A1 true PL328228A1 (en) 1999-01-18

Family

ID=7783568

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328228A PL328228A1 (en) 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system

Country Status (16)

Country Link
EP (1) EP0879234A1 (cs)
JP (1) JP2000503972A (cs)
KR (1) KR19990081970A (cs)
CN (1) CN1209807A (cs)
AR (1) AR005549A1 (cs)
AU (1) AU715785B2 (cs)
BR (1) BR9707467A (cs)
CA (1) CA2244136A1 (cs)
CZ (1) CZ231898A3 (cs)
DE (1) DE19602505A1 (cs)
HU (1) HUP9900980A2 (cs)
NO (1) NO983439L (cs)
PL (1) PL328228A1 (cs)
SK (1) SK99298A3 (cs)
WO (1) WO1997027186A1 (cs)
ZA (1) ZA97572B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6984600A (en) * 1999-09-09 2001-04-24 H. Lundbeck A/S 5-aminoalkyl and 5-aminocarbonyl substituted indoles
CN1260227C (zh) 1999-11-10 2006-06-21 武田药品工业株式会社 含氮的五元杂环化合物
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
PT1309591E (pt) 2000-08-14 2007-04-30 Ortho Mcneil Pharm Inc Pirazoles substituídos
KR20050036882A (ko) * 2001-11-14 2005-04-20 메르크 파텐트 게엠베하 향정신제로서의 피라졸 유도체
BRPI0617204A2 (pt) 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
JP2009515833A (ja) * 2005-10-24 2009-04-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 3−ピペリジン−4−イル−インドールorl−1受容体モジュレーター
TWI548630B (zh) * 2011-04-06 2016-09-11 Lg生命科學有限公司 1-(3-氰基-1-異丙基-吲哚-5-基)吡唑-4-羧酸結晶型及其製造方法
KR20220060488A (ko) * 2020-11-04 2022-05-11 주식회사 엘지화학 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산의 결정성 입자의 제조방법 및 이를 포함하는 약학적 조성물
CN119698412A (zh) * 2023-07-24 2025-03-25 上海翊石医药科技有限公司 一类5-ht2a受体激动剂及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060816C3 (de) * 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
DE2258033A1 (de) * 1972-11-27 1974-05-30 Merck Patent Gmbh Verfahren zur herstellung von pyrazolderivaten
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
US5045550A (en) * 1990-09-20 1991-09-03 Warner-Lambert Co. Substituted tetrahydropyridines as central nervous system agents
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine

Also Published As

Publication number Publication date
CN1209807A (zh) 1999-03-03
JP2000503972A (ja) 2000-04-04
NO983439D0 (no) 1998-07-24
AU1443297A (en) 1997-08-20
WO1997027186A1 (de) 1997-07-31
BR9707467A (pt) 1999-07-20
HUP9900980A2 (hu) 1999-07-28
AR005549A1 (es) 1999-06-23
KR19990081970A (ko) 1999-11-15
AU715785B2 (en) 2000-02-10
ZA97572B (en) 1997-08-04
CZ231898A3 (cs) 1998-10-14
EP0879234A1 (de) 1998-11-25
CA2244136A1 (en) 1997-07-31
SK99298A3 (en) 1999-01-11
NO983439L (no) 1998-09-25
DE19602505A1 (de) 1997-07-31

Similar Documents

Publication Publication Date Title
ZA979985B (en) N-substituted 2-cyanopyrrolidines.
HU9503402D0 (en) Neurokinin receptor antagonists
ZA977011B (en) Muscarinic antagonists.
ZA977969B (en) Reflux inhibitors.
GB9719141D0 (en) Stabilizer combination
IL129122A0 (en) N-substituted azaheterocyclic compounds
CY2408B1 (en) Paroxetine controlled release compositions.
GB9605027D0 (en) Quinoxalinediones
HUP9904622A3 (en) 1,4-di-sustituted piperidines as muscarinic antagonists
GB9714129D0 (en) Azetidines
PL342732A1 (en) 1-(heteroarylpropyl- or -prop-2-enyl)-4 benzylpiperidine as antagopnists nmda receptor
HRP970006A2 (en) Azetidines
HRP970302B1 (en) Overvoltage sink
AU3567195A (en) Neurokinin antagonists
AU2446297A (en) Substituted piperazines and piperidines as central nervous system agents
PL328228A1 (en) 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system
DE69629454D1 (en) Antipsychotische 4-(1h-indolyl-1-yl)-1-substituierte piperidine derivate
ZA978792B (en) N-substituted azaheterocyclic compounds.
PL334569A1 (en) Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for treating the central nervous system
AU4376997A (en) N-substituted azaheterocyclic compounds
HRP970094A2 (en) 1,4-dihydropyridine compounds
GB2315006B (en) Equestrian bit
SI0751939T1 (en) Naphthylamides as central nervous system agents
SI0937040T1 (en) N-substituted 2-cyanopyrrolidines
ZA9710450B (en) Suspension unit